Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
Following our announcement on 18 November 2008, requests have now been sent to marketing authorisation (MA) holders for products containing:
i) carboplatin and
ii) budesonide
where product information has not already been updated. Further information is available on our Medicines for Children page.
› 18 November 2008 - MHRA announces an exercise to update Summaries of Product Characteristics (SmPCs) to include paediatric information following completion of European work-sharing procedures
›
Medicines for children
